Robert Iaropoli

Robert Iaropoli serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of critical scientific and technical resources. He manages a portfolio of contracts focused on laboratory diagnostics, biomedical research support, and data-driven public health infrastructure, ensuring timely access to high-integrity products and services essential for disease surveillance and outbreak response. His work directly enables CDC’s operational readiness by securing advanced diagnostic platforms, analytical tools, and specialized consulting services aligned with national health security priorities. Iaropoli maintains consistent procurement relationships with leading providers including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid, partnering with organizations capable of delivering complex, regulated solutions in clinical diagnostics, biosafety, and epidemiological analytics. His contracting approach emphasizes vendor reliability, regulatory compliance, and technical scalability, often engaging industry leaders with proven track records in federal health programs. These partnerships are characterized by long-term engagement and performance-based acquisition strategies that prioritize mission-critical outcomes over transactional procurement. His procurement patterns reflect a strong preference for open competition, with 75% of acquisitions conducted without set-asides, while maintaining a deliberate 25% allocation to Total Small Business Set-Asides under FAR 19.5. This balance underscores a commitment to fostering innovation through small business participation without compromising the agency’s need for high-capacity, mission-ready vendors. He actively promotes equitable access for small businesses while ensuring procurement integrity and operational continuity. Iaropoli’s primary technical focus lies in NAICS 325120 (Industrial Gas Manufacturing), supporting laboratory gas systems and biosafety infrastructure, and NAICS 541690 (Other Scientific and Technical Consulting Services), which includes expert advisory services for epidemiological modeling and diagnostic protocol development. His expertise spans the procurement of specialized reagents, point-of-care diagnostic devices, and technical services critical to CDC’s infectious disease response capabilities.